The company that produces the tablets has said the medication is mislabeled with the incorrect strength on the carton.

The company is worried mislabeling could lead to unintentionally taking higher doses and adverse side effects.

Endo USA, Inc., affiliated to generics and specialty branded pharmaceutical company Endo, Inc., has expanded its recall of Clonazepam ...

(RTTNews) - Endo USA, Inc., affiliated to generics and specialty branded pharmaceutical company Endo, Inc., has expanded its recall of Clonazepam Orally Disintegrating Tablets (C-IV), according to ...

Endo USA is expanding its previous recall of orally disintegrating clonazepam tablets to include more than a dozen additional product lots, the company said in a notice posted on the FDA’s ...

To date, Endo has not received any reports of adverse events associated with this product recall. Clonazepam Orally Disintegrating Tablets are indicated alone or as an adjunct in the treatment of ...

Credit: Endo, Inc At this time, there have been no reports of adverse events related to this recall. While the blister strips within the cartons reflect the correct strength and lot number, the ...

Endo Inc., based in Pennsylvania, has announced a voluntary recall of 16 lots of Clonazepam Orally Disintegrating Tablets after it discovered that a number of cartons may have been printed with ...